Ind-Swift Laboratories Operational Benchmarking
₹353.85-3.35%close, 9 Oct 2026
- Market cap
- ₹3,073 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹254.77 – ₹477.70
Ind-Swift Laboratories compared with sector peers on revenue, market capitalization, valuation, and return metrics.
Ind-Swift Laboratories sector benchmarking & peer comparison
Operational and financial KPI comparison against sector peers.
| Company | LTP (₹) | P/E | Market Cap (₹ cr) | Div Yield | Qtr Sales (₹ cr) | ROCE % |
|---|---|---|---|---|---|---|
| Ind-Swift Laboratories Limited | ₹353.85 | 22.5 | 3,073 | 1.2% | 768 | 14.5% |
| Median (1 Cos) | ₹353.85 | 22.5 | 3,073 | 1.2% | 768 | 14.5% |
Source: NSE sector index filings and financial statements. Data as of 9 October 2026. How this data is compiled.
Same Data For Peers
- IOL Chemicals and Pharmaceuticals Limited operational benchmarking
- Indraprastha Medical Corporation Limited operational benchmarking
- IPCA Laboratories Limited operational benchmarking
- Indo Us Biotech Limited operational benchmarking
- Jagsonpal Pharmaceuticals Limited operational benchmarking
- Indoco Remedies Limited operational benchmarking
Trade Ind-Swift Laboratories With ATS
Track INDSWFTLAB live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.